Prevalence of occult hepatitis B virus infection in hemodialysis patients from egypt with or without hepatitis C virus infection

Hepatitis Monthly

Volumn 12, Issue 4, 2012, Pages 253-258

  Abu El Makarem, Mona A ^a   Hamid, Mohammed Abdel ^a   Aleem, Ashraf Abdel ^a   Ali, Ahmed ^a   Shatat, Mohammed ^a   Sayed, Douaa ^b   Deaf, Ali ^a   Hamdy, Lamia ^a   Tony, Effat A ^c  

^a MINIA UNIVERSITY   (Egypt)

^b Assiut University Faculty of Medicine   (Egypt)

^c ASSIUT UNIVERSITY   (Egypt)

Author keywords

Egypt; Hemodialysis; Hepatitis B; Hepatitis C; Prevalence

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HEPATITIS B (E) ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OCCULT HEPATITIS B; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROPREVALENCE; VIRUS HEMAGGLUTINATION;

EID: 84861130782     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.665     Document Type: Article

References (32)

1. Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S. Hepatitis B and C in dialysis units in Iran: changing the epidemiology. Hemodial Int. 2008;12(3):378-382.
2. Fabrizi F, Messa PG, Lunghi G, Aucella F, Bisegna S, Mangano S, et al. Occult hepatitis B virus infection in dialysis patients: a multi-centre survey. Aliment Pharmacol Ther. 2005;21(11):1341-1347.
3. Reddy GA, Dakshinamurthy KV, Neelaprasad P, Gangadhar T, Lak-shmi V. Prevalence of HBV and HCV dual infection in patients on haemodialysis. Indian J Med Microbiol. 2005;23(1):41-43.
4. Wong PN, Fung TT, Mak SK, Lo KY, Tong GM, Wong Y, et al. Hepatitis B virus infection in dialysis patients. J Gastroenterol Hepatol. 2005;20(11):1641-1651.
5. Fabrizi F, Lunghi G, Martin P. Hepatitis B virus infection in hemodi-alysis: recent discoveries. J Nephrol. 2002;15(5):463-468.
6. Hollinger FB, Habibollahi P, Daneshmand A, Alavian SM. Occult Hepatitis B Infection in Chronic Hemodialysis Patients: Current Concepts and Strategy. Hepat Mon. 2010;10(3):199-204.
7. Fang Y, Shang QL, Liu JY, Li D, Xu WZ, Teng X, et al. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. J Infect. 2009;58(5):383-388.
8. Georgiadou SP, Zachou K, Liaskos C, Gabeta S, Rigopoulou EI, Dale-kos GN. Occult hepatitis B virus infection in patients with autoimmune liver diseases. Liver Int. 2009;29(3):434-442.
9. Ramezani A, Banifazl M, Eslamifar A, Aghakhani A. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J Infect Dev Ctries. 2010;4(10):658-661.
10. Shire NJ, Rouster SD, Rajicic N, Sherman KE. Occult hepatitis B in HIV-infected patients. J Acquir Immune Defic Syndr. 2004;36(3):869-875.
11. Tamori A, Hayashi T, Shinzaki M, Kobayashi S, Iwai S, Enomoto M, et al. Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus. J Med Virol. 2009;81(6):1009-1014.
12. Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology. 2004;39(1):51-57.
13. Toyoda H, Hayashi K, Murakami Y, Honda T, Katano Y, Nakano I, et al. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan. J Med Virol. 2004;73(2):195-199.
14. Attia MA. Prevalence of hepatitis B and C in Egypt and Africa. Antivir Ther. 1998;3(Suppl 3):1-9.
15. Khattab MA, Eslam M, Sharwae MA, Hamdy L. Seroprevalence of hepatitis C and B among blood donors in Egypt: Minya Governor-ate, 2000-2008. Am J Infect Control. 2010;38(8):640-641.
16. World Health Organization. Hepatitis B. Fact sheet No 204. WHO. [updated 2008 August]; Available from: http://www.who.int/me-diacentre/factsheets/fs204/en/
17. Anwar W, Sarwar M, Hussain AB, Tariq WU, Saif M. Significance of occult HBV infection in patients with chronic hepatitis C. J Coll Physicians Surg Pak. 2006;16(3):192-195.
18. Kaneko S, Feinstone SM, Miller RH. Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique. J Clin Microbiol. 1989;27(9):1930-1933.
19. Azab Me S, el Zayat EA. Evaluation of purified antigens in hae-magglutination test (IHA) for determination of cross re activities in diagnosis of fascioliasis and schistosomiasis. J Egypt Soc Parasitol. 1996;26(3):677-685.
20. Goral V, Ozkul H, Tekes S, Sit D, Kadiroglu AK. Prevalence of occult HBV infection in haemodialysis patients with chronic HCV. World J Gastroenterol. 2006;12(21):3420-3424.
21. Minuk GY, Sun DF, Greenberg R, Zhang M, Hawkins K, Uhanova J, et al. Occult hepatitis B virus infection in a North American adult he-modialysis patient population. Hepatology. 2004;40(5):1072-1077.
22. Yakaryilmaz F, Gurbuz OA, Guliter S, Mert A, Songur Y, Karakan T, et al. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Ren Fail. 2006;28(8):729-735.
23. Siagris D, Christofidou M, Triga K, Pagoni N, Theocharis GJ, Gou-menos D, et al. Occult hepatitis B virus infection in hemodialysis patients with chronic HCV infection. J Nephrol. 2006;19(3):327-333.
24. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49(4):652-657.
25. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol. 2007;46(1):160-170.
26. Raimondo G, Pollicino T, Romano L, Zanetti AR. A 2010 update on occult hepatitis B infection. Pathol Biol (Paris). 2010;58(4):254-257.
27. El-Zayadi AR, Ibrahim EH, Badran HM, Saeid A, Moneib NA, Shemis MA, et al. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission. Transfus Med. 2008;18(1):55-61.
28. Gwak GY, Huh W, Lee DH, Min BH, Koh KC, Kim JJ, et al. Occult hepatitis B virus infection in chronic hemodialysis patients in Korea. Hepatogastroenterology. 2008;55(86-87):1721-1724.
29. Cabrerizo M, Bartolome J, Caramelo C, Barril G, Carreno V. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology. 2000;32(1):116-123.
30. Chemin I, Trepo C. Clinical impact of occult HBV infections. J Clin Virol. 2005;34(Suppl 1):S15-S21.
31. Chemin I, Zoulim F. Hepatitis B virus induced hepato cellular carcinoma. Cancer Lett. 2009;286:52-59.
32. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med. 1999;341(1):22-26.